144 related articles for article (PubMed ID: 9643128)
1. [Prevention of opportunistic infections in HIV-infected adults].
Furrer H; Malinverni R
Ther Umsch; 1998 May; 55(5):302-9. PubMed ID: 9643128
[TBL] [Abstract][Full Text] [Related]
2. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
[TBL] [Abstract][Full Text] [Related]
3. Interruption of prophylaxis for major opportunistic infections in HIV-infected patients receiving triple combination antiretroviral therapy.
Jubault V; Pacanowski J; Rabian C; Viard JP
Ann Med Interne (Paris); 2000 May; 151(3):163-8. PubMed ID: 10896967
[TBL] [Abstract][Full Text] [Related]
4. [Prevention and treatment of opportunistic infections].
Nevot Falcó S; Bartralot Soler J
Allergol Immunopathol (Madr); 1998; 26(3):144-50. PubMed ID: 9675398
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
[TBL] [Abstract][Full Text] [Related]
6. HIV infection and AIDS.
Lloyd A
P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
[TBL] [Abstract][Full Text] [Related]
7. Opportunistic infections: an update.
Furrer H; Fux C
J HIV Ther; 2002 Feb; 7(1):2-7. PubMed ID: 11956497
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis for opportunistic infections in an era of effective antiretroviral therapy.
Powderly WG
Clin Infect Dis; 2000 Aug; 31(2):597-601. PubMed ID: 10987727
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of wasting and opportunistic infections in HIV-infected patients in West Africa: a realistic and necessary strategy before antiretroviral treatment].
Ledru é ; Sanou PT; Dembele M; Dahourou H; Zoubga A; Durand G
Sante; 1999; 9(5):293-300. PubMed ID: 10657773
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
[TBL] [Abstract][Full Text] [Related]
11. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
12. A prospective multicentre study of discontinuing prophylaxis for opportunistic infections after effective antiretroviral therapy.
Green H; Hay P; Dunn DT; McCormack S;
HIV Med; 2004 Jul; 5(4):278-83. PubMed ID: 15236617
[TBL] [Abstract][Full Text] [Related]
13. [Care for the HIV-infected person].
Sierra-Madero JG
Salud Publica Mex; 1995; 37(6):520-4. PubMed ID: 8599125
[TBL] [Abstract][Full Text] [Related]
14. [Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases].
García Vázquez E; de Górgolas Hernández M; García Delgado R; Fernández Guerrero ML
Med Clin (Barc); 1999 Jun; 113(3):89-90. PubMed ID: 10464742
[TBL] [Abstract][Full Text] [Related]
15. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
16. I hear you knockin' (but you can't come in): potent new HIV therapies are shutting out opportunistic infections.
Fichtenbaum CJ
Res Initiat Treat Action; 1998 Jul; 4(4):3-7. PubMed ID: 11365645
[TBL] [Abstract][Full Text] [Related]
17. [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].
Koch A; Kothe H; Braun J; Kämmerer R; Friedrich HJ; Dalhoff K
Pneumologie; 1998 Nov; 52(11):614-21. PubMed ID: 9885511
[TBL] [Abstract][Full Text] [Related]
18. Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.
López-Palomo C; Martín-Zamorano M; Benítez E; Fernández-Gutiérrez C; Guerrero F; Rodríguez-Iglesias M; Girón-González JA
J Med Virol; 2004 Apr; 72(4):517-24. PubMed ID: 14981752
[TBL] [Abstract][Full Text] [Related]
19. [Which are the vaccines that human immunodeficiency virus infected patients must receive?].
Valencia Ortega ME; González Lahoz JM
An Med Interna; 1998 Aug; 15(8):439-42. PubMed ID: 9780428
[TBL] [Abstract][Full Text] [Related]
20. Update: prophylaxis for HIV opportunistic infections.
Murphy MJ
Fac Notes (New Orleans La); 1998; 10(1):5-6. PubMed ID: 11365025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]